Memorial Sloan Kettering Cancer Center’s chief executive emailed all staff telling them they “need to do a better job” of disclosing industry relationships in the wake of a published report that the cancer center’s chief medical officer failed to disclose his extensive industry ties; the remedy to balance billing (the surprise bills patients receive after their insurance plan has paid the contracted amount with a provider) may lie at the federal or state level or possibly the courts; marijuana health research applications are stalled at the Drug Enforcement Administration, 2 years after it began taking the requests.
Memorial Sloan Kettering Cancer Center’s chief executive emailed all staff telling them they “need to do a better job” of disclosing industry relationships in the wake of a published report that the cancer center’s chief medical officer failed to disclose his extensive industry ties in dozens of research articles since 2013. The New York Times said the email referred to an article published over the weekend by the paper and ProPublica. The article found that José Baselga, MD, had received millions of dollars in consulting fees and ownership interests in healthcare companies, but he did not mention those ties in appearances at scientific conferences and in journal articles.
The remedy to balance billing (the surprise bills patients receive after their insurance plan has paid the contracted amount with a provider) may lie at the federal or state level or possibly the courts, Kaiser Health News reported. Kaiser examined one facet of the issue as it applies to self-funded plans under the federal Employee Retirement Income Security Act of 1974, or ERISA. ERISA does not prohibit balance billing, even as more states move to protect consumers against surprise medical bills.
Marijuana health research applications are stalled at the Drug Enforcement Administration, 2 years after it began taking the requests, The Wall Street Journal reported. The Department of Justice, led by Attorney General Jeff Sessions, a longtime critic of marijuana use, is not eager to process the applications, leading to bipartisan frustration. Researchers, including those working with veterans, want to study a wider variety of marijuana to know if it can be effective in alleviating pain, fighting seizures, combating depression, or relieving posttraumatic stress.
Allergies and Asthma Prevalence Rise With Climate Change Extremes and Pollutants
June 30th 2025Increasing environmental events driven by climate change and human activity exacerbate allergy and asthma conditions, further compounded by exposure to persistent pollutants like per-and polyfluoroalkyl substances and microplastics.
Read More
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen